Robert S. Rosenson, M.D. – FDA Inspection, Oct 29, 2020

Record Details

This FDA Inspection record concerns Robert S. Rosenson, M.D., with an inspection on October 29, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Robert S. Rosenson, M.D.
Inspection Date: October 29, 2020
Product Type: Drugs
Office: Center for Drug Evaluation and Research

View Company Profile

ID · fadc0965-4595-4d06-80d6-5f55860a7f72

Inspection Facts

No Action Indicated (NAI)

No objectionable conditions or practices were found during the inspection.

Inspection number: 1134249
FDA center: Human Drugs
Project area: Bioresearch Monitoring

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Robert S. Rosenson, M.D.

FDA Inspection

Robert S. Rosenson, M.D.October 29, 2020